What is Centinel Spine?
Centinel Spine stands as the largest privately-held entity dedicated exclusively to anterior column reconstruction. With a legacy spanning over three decades, the company has established a robust reputation for delivering clinically-proven solutions, including its flagship Total Disc Replacement and Integrated Interbody systems. The organization is defined by its focus on the Sentinel Sign, a radiographic benchmark for successful fusion, which serves as a testament to its engineering precision. By maintaining a continuum of trusted, brand-name products, Centinel Spine effectively bridges the gap between traditional fusion techniques and modern motion-preservation, positioning itself as a critical partner for surgeons and healthcare systems globally.
How much funding has Centinel Spine raised?
Centinel Spine has raised a total of $192.3M across 2 funding rounds:
Private Equity
$132.3M
Debt
$60M
Private Equity (2017): $132.3M, investors not publicly disclosed
Debt (2025): $60M led by SLR Capital Partners, LLC
Key Investors in Centinel Spine
SLR Capital Partners, LLC
SLR Capital Partners, LLC is a leading independent asset manager specializing in flexible debt capital solutions for U.S. middle-market businesses, focusing on senior secured loans and specialty finance.
Undisclosed Investor
An undisclosed institutional investor participating in the company's private equity financing round to support long-term growth.
Undisclosed Investor
An undisclosed investor providing strategic backing to facilitate the expansion of clinical orthopedic solutions.
What's next for Centinel Spine?
With the recent injection of capital, Centinel Spine is well-positioned to accelerate its strategic growth trajectory within the competitive spine market. The company is expected to prioritize the scaling of its clinical research programs and the further penetration of its integrated interbody portfolios into international markets. As the healthcare landscape shifts toward value-based care, Centinel Spine's focus on clinically-validated outcomes provides a distinct competitive advantage. Future initiatives will likely involve the optimization of supply chain efficiencies and the potential development of next-generation motion-preservation technologies, ensuring the firm remains at the forefront of spinal innovation while maintaining its status as a leader in anterior column reconstruction.
See full Centinel Spine company page
